|
Market Closed -
NYSE
07:00:02 27/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 45.58 USD | -0.24% |
|
+1.18% | -52.20% |
| 23/10 | Laboratory operator Quest reports cyber breach affecting patient records | RE |
| 21/10 | Abbott cuts 2026 sales growth view, plans to spin off nutrition business | RE |
| Market Cap | 66.06B 59.07B 54.65B 49.48B 92.61B 6,285B 94.12B 658B 260B 3,287B 248B 243B 10,408B | P/E 2026 * |
17.3x | P/E 2027 * | 18.1x |
|---|---|---|---|---|---|
| Enterprise Value | 72.47B 64.8B 59.95B 54.28B 102B 6,894B 103B 721B 285B 3,606B 272B 266B 11,418B | EV / Sales 2026 * |
3.43x | EV / Sales 2027 * | 3.23x |
| Free-Float |
82.47% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| BSX | Delayed | |
CBOE
| BSX | Real-time | |
Tradegate
| BSX | Real-time | |
Xetra
| BSX | Delayed | |
Boerse Muenchen
| BSX | Real-time | |
London S.E.
| 0HOY | Delayed | |
Mexican S.E.
| BSX * | End-of-day quote | |
Deutsche Boerse AG
| BSX | Delayed | |
Borsa Italiana
| 1BSX | End-of-day quote | |
Wiener Boerse
| BSXC | End-of-day quote | |
Börse Stuttgart
| BSX | Delayed | |
Swiss Exchange
| BSX | Delayed | |
Swiss Exchange
| BSX | Delayed | |
CBOE
| 0HOY | Real-time | |
CBOE
| Real-time |
Last Transcript: Boston Scientific Corporation
| 1 day | -0.24% | ||
| 1 week | +1.18% | ||
| Current month | +4.42% | ||
| 1 month | +3.78% | ||
| 3 months | +3.01% | ||
| 6 months | -26.57% | ||
| Current year | -52.20% |
| 1 week | 43.92 | 46.16 | |
| 1 month | 41.38 | 46.16 | |
| Current year | 41.38 | 100.9 | |
| 1 year | 41.38 | 105.65 | |
| 3 years | 41.38 | 109.5 | |
| 5 years | 34.98 | 109.5 | |
| 10 years | 19.67 | 109.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 61 | 01/11/2011 |
Jonathan Monson
DFI | Director of Finance/CFO | 52 | 30/06/2025 |
Kenneth Stein
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CHM | Chairman | 61 | 03/05/2016 |
Edward Ludwig
BRD | Director/Board Member | 74 | 01/03/2014 |
Ellen Zane
BRD | Director/Board Member | 74 | 15/04/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 25/8/26 | Buy | Director | 2,040 | 0.0001% | ||
| 11/8/26 | Other | Controller/Auditor | 2,930 | 0.0002% | ||
| 10/8/26 | Other | Chief Financial Officer | 9,908 | 0.0007% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.24% | +1.18% | -54.92% | -8.44% | 66.06B | ||
| +1.64% | +0.81% | +19.63% | +55.60% | 253B | ||
| +1.07% | +3.81% | +4.47% | +20.29% | 164B | ||
| -0.15% | +4.26% | -17.36% | +74.03% | 157B | ||
| -1.50% | +0.44% | +8.59% | +67.34% | 51.52B | ||
| +1.03% | +3.07% | -14.62% | -8.28% | 52.64B | ||
| +1.67% | +3.83% | +19.00% | +44.25% | 52.2B | ||
| +1.67% | +3.57% | +18.87% | +68.69% | 49.61B | ||
| +0.51% | +5.00% | +26.84% | +86.53% | 44.8B | ||
| +0.60% | +3.19% | +170.74% | +142.80% | 40.93B | ||
| Average | +0.47% | +2.92% | +18.12% | +54.28% | 93.14B | |
| Weighted average by Cap. | +0.71% | +2.67% | +9.82% | +50.36% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.13B 18.89B 17.48B 15.82B 29.62B 2,010B 30.1B 210B 83.19B 1,051B 79.29B 77.6B 3,329B | 22.14B 19.79B 18.31B 16.58B 31.03B 2,106B 31.54B 220B 87.17B 1,102B 83.08B 81.31B 3,488B |
| Net income | 3.75B 3.36B 3.1B 2.81B 5.26B 357B 5.35B 37.36B 14.78B 187B 14.09B 13.78B 591B | 3.68B 3.29B 3.04B 2.75B 5.15B 350B 5.24B 36.59B 14.47B 183B 13.8B 13.5B 579B |
| Net Debt | 6.41B 5.73B 5.3B 4.8B 8.99B 610B 9.13B 63.82B 25.24B 319B 24.06B 23.54B 1,010B | 5.49B 4.91B 4.55B 4.12B 7.7B 523B 7.83B 54.7B 21.64B 273B 20.62B 20.18B 866B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/10/26 | USD 45.58 | -0.24% | 11,928,715 |
| 23/10/26 | USD 45.69 | -0.70% | 8,772,772 |
| 22/10/26 | USD 46.01 | +3.37% | 16,395,574 |
| 21/10/26 | USD 44.51 | -2.35% | 15,193,231 |
| 20/10/26 | USD 45.58 | +1.18% | 16,013,159 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSX Stock
Select your edition
All financial news and data tailored to specific country editions


















